A Study to Assess the Efficacy & Safety of Twice-Daily Dose Regimens of an

A Study to Assess the Efficacy and Safety of Twice-Daily Dose Regimens of an Oral Calcimimetic Agent AMG 073 (Cinacalcet) in Primary Hyperparathyroidism (PHPT)

Hyperparathyroidism, Primary Clinical Trial

Official title:
A Double-Blind, Randomized, Placebo-Controlled, Multicenter Dose-Titration Study to Assess the Efficacy and Safety of Twice-Daily Dose Regimens of an Oral Calcimimetic Agent AMG 073 (Cinacalcet) in Primary Hyperparathyroidism (PHPT)

Status Completed

Clinical Trial Summary

This randomized, placebo-controlled study in patients with primary HPT was designed to evaluate the efficacy, safety, pharmacokinetics, and health-related quality of life (HRQOL) of AMG 073 when administered 2 times a day (BID). The study consisted of 3 phases: a 12-week dose-titration phase, a 12-week maintenance phase, and a 28-week follow-up phase.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00936650
Study type	Interventional
Source	Amgen
Contact
Status	Completed
Phase	Phase 2
Start date	November 1999
Completion date	June 2001

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03764007` - 18F-Fluorocholine for the Detection of Parathyroid Adenomas	Phase 2/Phase 3
Not yet recruiting	`NCT05556499` - The Bone-parathyroid Crosstalk in Primary Hyperparathyroidism
Completed	`NCT00928408` - PRIMARA: A Prospective Descriptive Observational Study to Review Mimpara (Cinacalcet) Use in Patients With Primary Hyperparathyroidism in Clinical Practice
Completed	`NCT00936988` - A Multicenter, Open-label Extension Study to Assess the Long-term Safety and Efficacy of an Oral Calcimimetic Agent AMG 073 (Cinacalcet) in Primary Hyperparathyroidism	Phase 2
Recruiting	`NCT04948671` - Primary Hyperparathyroidism and Gut Microbiota
Completed	`NCT02417389` - Efficacy of Cinacalcet in the Control of Primary Hyperparathyroidism	Phase 4
Completed	`NCT00975221` - Efficacy and Safety Study of Cinacalcet for the Treatment of Hypercalcemia in Patients With Primary Hyperparathyroidism Unable to Undergo Parathyroidectomy	Phase 3
Recruiting	`NCT04895631` - 18F-Fluorocholine Positron Emission Tomography (PET) for the Detection of Parathyroid Adenomas	Phase 3
Not yet recruiting	`NCT04126954` - Study on the Use of Cinacalcet in Phosphocalcic Context.
Recruiting	`NCT05152927` - Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy	N/A
Recruiting	`NCT06230380` - Autofluorescence in Surgery for Primary Hyperparathyroidism	N/A
Completed	`NCT03091140` - Alterations in Muscle's Functional Characteristics After Parathyroid Surgery for Primary Hyperparathyroidism.
Completed	`NCT03324893` - FCH PET/MRI Parathyroid Localization	N/A
Completed	`NCT05347082` - Frequency of Hyperparathyroidism in Postmenopausal Osteoporosis and Its Treatment	N/A